Data / Form D filings / Reprise Biomedical, Inc.
Reprise Biomedical, Inc.: Form D filings
Reprise Biomedical, Inc., a biotechnology company in Plymouth, MN, filed 10 Form D notices with the SEC between 2019 and 2026. The latest, on July 1, 2026, reports $9.2 million sold of a $10 million offering to 43 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17400 Medina Rd., Ste. 100, Plymouth, MN, 55447
- Phone
- (763) 284-6780
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782236
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Amendment | $10,000,000 | $9,246,100 | $753,900 | 43 | May 14, 2026 | sec.gov |
| May 21, 2026 | New notice | $8,000,000 | $1,450,000 | $6,550,000 | 4 | May 14, 2026 | sec.gov |
| Jul 11, 2025 | New notice | $7,000,000 | $6,356,956 | $643,044 | 14 | Jun 26, 2025 | sec.gov |
| Dec 13, 2023 | Amendment | $12,500,000 | $7,982,500 | $4,517,500 | 77 | Oct 19, 2023 | sec.gov |
| Nov 2, 2023 | New notice | $10,000,000 | $4,550,000 | $5,450,000 | 17 | Oct 19, 2023 | sec.gov |
| Jan 25, 2023 | Amendment | $15,297,306 | $15,297,306 | 64 | Dec 20, 2022 | sec.gov | |
| Jan 3, 2023 | New notice | $14,800,673 | $13,042,306 | $1,758,367 | 55 | Dec 20, 2022 | sec.gov |
| Mar 31, 2021 | Amendment | $5,000,000 | $4,995,000 | $5,000 | 39 | Nov 13, 2020 | sec.gov |
| Nov 25, 2020 | New notice | $5,000,000 | $2,775,000 | $2,225,000 | 36 | Nov 13, 2020 | sec.gov |
| Jul 12, 2019 | New notice | $12,500,000 | $12,500,000 | 51 | Jun 28, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carrie Powers | Executive Officer, Director | |
| Jake Isenburg | Executive Officer | |
| Tom Kouchoukos | Executive Officer | |
| Steve Jagodzinski | Executive Officer | |
| Greg Smock | Executive Officer | |
| Jerrod Krueger | Executive Officer | |
| Heather Kotila | Executive Officer | |
| Howard Root | Director | |
| Ronald Eibensteiner | Director | |
| Erwin Kelen | Director | |
| Phil Nalbone | Director | |
| Alan Woldt | Director | |
| Jeff Duncan | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Reprise Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.